Monday, 16 Sep 2019

You are here

Initiation of Urate-Lowering Therapy During Gout Attacks

A retrospective analysis examined whether it's better to initiate urate-lowering therapy (ULT) during or after an attack of acute gout.

Patients on ULT for > 3yrs were divided into 2 groups: 1) group 1 included 123 patients who started ULT during an acute attack of gout; and 2) group 2 included 457 patients who were given ULT after an acute attack. Both groups had similar mean serum urate levels at the start (7.8±1.4mg/dL vs. 7.9±1.9mg/dL, respectively) and both equally achieved a uric acid target level of <6.0mg/dL (66.7 and 65.6%, respectively).

The time to achieve target SUA levels was shorter in group 1 than in group 2, but the number of flares were higher in group 1 compared to those in group 2. Chronic kidney disease was lower in group 1 than in group 2. Although initiation of ULT during the acute gouty attack decreased the time required to reach the target urate levels and the incidence of chronic kidney disease, but the attack rate was greater in the first 12 weeks.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Modifiable Risk Factors for Hyperuricemia

Choi and colleagues have shown that four modifiable risk factors (BMI, the DASH diet, alcohol use, and diuretic use) could individually account for a notable proportion of observed hyperuricemia. 

Researchers examine modifiable risk factors for hyperuricemia and how this could be prevented through risk factor modification in the general population.

Opioids Overused in Acute Gout

Opioids were commonly given to patients as a treatment for acute gout attacks, despite the availability of other effective and appropriate therapies, a retrospective study found.

Allopurinol Fails to Curtail Hypertension

Editor's note: July 1 - 5, RheumNow is running the best of the EULAR 2019 meeting. A novel trial presented at EULAR 2019 last week assessed whether the use of urate-lowering therapy (ULT) would control hypertension in those at risk; however, results of this trial were largely negative.

Hypertension is one of the many comorbidities that plagues gout patients.

Allopurinol Fails to Curtail Hypertension

A novel trial presented at EULAR 2019 last week assessed whether the use of urate-lowering therapy (ULT) would control hypertension in those at risk; however, results of this trial were largely negative.

Hypertension is one of the many comorbidities that plagues gout patients.

Updated 2018 EULAR Recommendations for the Diagnosis of Gout

The first EULAR recommendations for the diagnosis of gout were published in 2006. A task force was formed and following a systematic review, they voted unanimously for changes in all items of the 2006 recommendations.